Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IDEAL Phase II Study of a Newly Designed Optical Coherence Tomography Probe During Transurethral Resection for Optimizing Bladder Cancer Diagnosis and Treatment

NCT06679920 is registered in ClinicalTrials.gov with Amsterdam UMC as lead sponsor.

NCT NCT06679920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06679920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IDEAL Phase II Study of a Newly Designed Optical Coherence Tomography Probe During Transurethral Resection for Optimizing Bladder Cancer Diagnosis and Treatment
Lead sponsor
Amsterdam UMC
Phase
Not applicable
Overall status
Recruiting
Start date
December 31, 2024
Completion date
April 30, 2025
Enrollment
15 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer